Endeavor

Is Immunotherapy Before and After Surgery a Better Strategy for Certain Cancers?

Several studies from the ASCO Annual Meeting suggest earlier use of immunotherapy improves survival for colon, head and neck and stomach cancers

Can Triplet Therapy Help Treat Symptomatic Melanoma Brain Metastases?

Targeted therapy combined with immunotherapy gave patients longer progression-free survival and higher response rates, study says

Drug Combination Proves More Effective for Patients with Advanced Stage 3 Melanoma

Results of a recent NCI-sponsored clinical trial point to lower disease progression and recurrence rates in patients with melanoma

New Drug Significantly Improves Outcomes for Patients with Polycythemia Vera

The therapy reduces the need for the therapeutic removal of blood and improves symptoms

Immunotherapy Combo Shows Promise as Pre-Surgical Treatment for Merkel Cell Carcinoma

More than half of patients had no detectable tumor cells after treatment with pembrolizumab and lenvatinib

Cancer Deaths Linked to Alcohol on the Rise in the U.S.

Increase seen mostly in men 55 and up, study finds

Study Says More Effective Skin Cancer Prevention Strategies Needed for Older Adults

Men 65 and older especially need targeted prevention

From Diagnosis to Advocacy: Melanoma Survivor Shows Why Clinical Trials Matter

Mary Margaret Braddock credits research, clinical trials and dedicated care teams for saving her life and giving others hope

Moffitt Study Finds Structural Barriers May Prevent Cancer Care for People Living With HIV

People with HIV in underserved ZIP codes face lower odds of receiving curative cancer care, according to study